发明名称 Injectable aqueous pharmaceutical compositions comprising a cyclodextrin, a hydrophobic drug, a co-solvent, and a preservative
摘要 The invention relates to injectable pharmaceutical compositions, methods of use and formulation, wherein the compositions comprise: one or more water soluble complexes, each complex comprising a cyclodextrin or a cyclodextrin derivative and a hydrophobic drug; at least one preservative; and at least one co-solvent. The compositions are effectively preserved in accordance with the European Pharmacopoeia 2011 Test for Efficacy of Antimicrobial Preservation, satisfying at least the B criteria as it applies to parenterals, and the United States Pharmacopeia 2011 Guidelines for Antimicrobial Effectiveness Testing, satisfying the criteria for Category 1 (injectable) products.
申请公布号 US9492552(B2) 申请公布日期 2016.11.15
申请号 US201214361677 申请日期 2012.11.27
申请人 JUROX PTY LTD 发明人 Pasloske Kirby Shawn;Lau Kai;Richardson Sarah Jane;Willis Amanda Aileen
分类号 A61K31/573;A61K47/40;C08L5/16;C08B37/16;A61K31/05;A61K31/403;A61K31/5415;A61K31/57;A61K47/48;B82Y5/00 主分类号 A61K31/573
代理机构 Thorpe North & Western, LLP 代理人 Thorpe North & Western, LLP
主权项 1. An injectable pharmaceutical composition complying with the European Pharmacopoeia 2011 Test for Efficacy of Antimicrobial Preservation, satisfying at least the B criteria for parenterals, and the United States Pharmacopeia 2011 Guidelines for Antimicrobial Effectiveness Testing for Category 1 (injectable) products comprising: per liter of water, 80 g 2-hydroxypropyl-β-cyclodextrin, 10 g alfaxalone, 8 g sodium chloride, 940 mg disodium phosphate, 450 mg potassium dihydrogen phosphate, 1 g to 1.5 g chlorocresol, and 150 g ethanol wherein the pH is adjusted to a pH in a range of 6.0 to 7.5 with a pH adjuster.
地址 New South Wales AU